COMPLICATED CASE HISTORIES
Drug Induced Mania in a Boy with High Functioning Autism
By Mustafa Deniz Tutkunkardas, Nahit Motavalli Mukaddes
-
Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients
By Robert R. Conley, MD and Deanna L. Kelly, PharmD, BCPP
-
Duloxetine for the Treatment of Major Depressive Disorder
By Charles B. Nemeroff, MD, PhD, Alan F. Schatzberg, MD, David J. Goldstein, MD, PhD, Michael J. Detke, MD, PhD, Craig Mallinckrodt, PhD, Yili Lu, PhD, and Pierre V. Tran, MD
-
ORIGINAL RESEARCHDuloxetine in Military Posttraumatic Stress Disorder
By Gerardo Villarreal, José M. Cañive, Lawrence A. Calais, Gregory Toney, Ashley K. Smith
-
Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders
By Charles B. Nemeroff, MD, PhD
-
Economic Impacts of Anxiety Disorders
By Ernst R. Berndt, PhD and Tamar Sisitsky, MA
-
Economics of Cancer Drug Development
By Michael Dickson, PhD, and Gene Reeder, PhD
-
EDITOR’S LETTER
Charles B. Nemeroff, MD, PhD
-
Effectiveness of a Brain-Computer Interface Based Programme for the Treatment of ADHD: A Pilot Study
By Choon Guan Lim, Tih-Shih Lee, Cuntai Guan, Daniel Shuen Sheng Fung, Yin Bun Cheung, Stephanie Sze Wei Teng, Haihong Zhang, K Ranga Krishnan
-
Effectiveness of Clozapine use in Delaying Hospitalization in Routine Clinical Practice: A 2 year Observational Study
By Kazare Nyakyoma, Richard Morriss
-
Evidence-Based MedicineEffects of Discontinuation of Paliperidone Long-Acting Injectable After Switching from Risperidone Long-Acting Injectable Switching
By Takafumi Watanabe, Atsurou Yamada
-
Efficacy and Tolerability of Controlled-Release Paroxetine
By Robert N. Golden, MD
